Elshorbagy, A., Lyons, A. R. M., Vallejo-Vaz, A. J., Stevens, C. A. T., Dharmayat, K. I., Brandts, J., . . . März, W. (2024). Association of BMI, lipid-lowering medication, and age with prevalence of type 2 diabetes in adults with heterozygous familial hypercholesterolaemia: A worldwide cross-sectional study. The lancet. Diabetes & Endocrinology, 12(11), . https://doi.org/10.1016/S2213-8587(24)00221-3
Chicago-Zitierstil (17. Ausg.)Elshorbagy, Amany, et al. "Association of BMI, Lipid-lowering Medication, and Age with Prevalence of Type 2 Diabetes in Adults with Heterozygous Familial Hypercholesterolaemia: A Worldwide Cross-sectional Study." The Lancet. Diabetes & Endocrinology 12, no. 11 (2024). https://doi.org/10.1016/S2213-8587(24)00221-3.
MLA-Zitierstil (9. Ausg.)Elshorbagy, Amany, et al. "Association of BMI, Lipid-lowering Medication, and Age with Prevalence of Type 2 Diabetes in Adults with Heterozygous Familial Hypercholesterolaemia: A Worldwide Cross-sectional Study." The Lancet. Diabetes & Endocrinology, vol. 12, no. 11, 2024, https://doi.org/10.1016/S2213-8587(24)00221-3.